Company Releases - Pharmaceutical Technology

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Advertise with us

Clinical Trials

Novartis finds Jakavi can help real-world blood cancer patients

EULAR 2018: key pipeline developments in psoriatic arthritis

Lanabecestat termination: another blow for BACE inhibitors

Cold Chain

Eli Lilly’s Olumiant: how will it far among JAK inhibitors?

ASCO 2018: Roche discusses TMB as a predictive biomarker for NSCLC

After positive vaccine study, VBI looks to untapped congenital CMV market

Diseases

Novartis finds Jakavi can help real-world blood cancer patients

EULAR 2018: key pipeline developments in psoriatic arthritis

EULAR 2018: Focus on infliximab biosimilars in rheumatoid arthritis

Drug Development

EULAR 2018: key pipeline developments in psoriatic arthritis

Lanabecestat termination: another blow for BACE inhibitors

EULAR 2018: Focus on infliximab biosimilars in rheumatoid arthritis

Manufacturing

Pfizer’s blockbuster drug Lyrica comes off-patent in 2018

Unlocking cell-free protein synthesis: biotech’s next big ticket?

GE provides FlexFactory platform to Xiangxue Pharmaceutical

Market Data

FDA approves Suboxone generic variant to treat opioid dependence

Lanabecestat termination: another blow for BACE inhibitors

EULAR 2018: Focus on infliximab biosimilars in rheumatoid arthritis

Technology

Innovators to watch from TLA’s HealthTech Innovator conference

Denali and AbCellera to collaborate on treating neurodegenerative disease

ASCO 2018: Roche’s polatuzumab vedotin results show promise in DLBCL